It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Coronavirus crisis has made Brazil an ideal vaccine laboratory

World / Science & Health Aug 16, 2020

Coronavirus crisis has made Brazil an ideal vaccine laboratory

by Manuela Andreoni and Ernesto Londono

With a medical manufacturing infrastructure and plenty of vaccine trial volunteers, Brazil has emerged as a potentially vital player in the scramble to end the pandemic.

Fujifilm to complete delayed Avigan clinical trials in Japan in September

National Aug 13, 2020

Fujifilm to complete delayed Avigan clinical trials in Japan in September

Fujifilm Holdings Corp. said Thursday it expects to complete clinical tests in Japan of the antiviral drug Avigan, a potential candidate treatment drug for COVID-19, in September, already behind schedule after a delay caused by difficulty in securing enough patient data. The last patient will ...

Vaccine confronts humanity with next moral test

Commentary / World Aug 10, 2020

Vaccine confronts humanity with next moral test

by John Authers

Who gets coronavirus protection first (and last)? Who profits (and loses)? What is “informed consent” (if it exists)? Divided societies face agonizing choices.

Japan and AstraZeneca set for deal on 100 million doses of virus vaccine

National / Science & Health Aug 7, 2020

Japan and AstraZeneca set for deal on 100 million doses of virus vaccine

The drugmaker is expected to begin clinical trials in Japan later this month to confirm the efficacy and safety of its vaccine, currently being tested overseas.

Pricing COVID-19 vaccines too high could backfire on big pharma

Commentary / World Aug 5, 2020

Pricing COVID-19 vaccines too high could backfire on big pharma

by Mihir Sharma

If vaccine makers make their products too expensive for the developing world, the whole idea of intellectual property could be blown up.

Gargle medicine can fight coronavirus, Osaka governor says, citing limited data

National Aug 4, 2020

Gargle medicine can fight coronavirus, Osaka governor says, citing limited data

by Gearoid Reidy

The governor of Osaka Prefecture touted the powers of gargling medicine to control the coronavirus and recommended its use, sending related shares jumping and clearing shelves of disinfectants even as some questioned the findings. Based on limited trial on a group of 41 patients with ...

Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people

National / Science & Health Aug 1, 2020

Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people

The agreement marks Japan's first advance deal for a vaccine to fight the coronavirus.

Taisho emerges as lead bidder for Takeda $3 billion consumer unit

Business / Corporate Jul 31, 2020

Taisho emerges as lead bidder for Takeda $3 billion consumer unit

Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter. The company is in advanced talks with Takeda on terms of a transaction, and the two parties aim ...

Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12

World / Science & Health Jul 30, 2020

Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12

by Jake Rudnitsky and Stepan Kravchenko

The conditional registration in August would still require trials to be conducted on another 1,600 people, and production is expected to begin in September.

Astra to pay Daiichi up to $6 billion for new cancer drug

Business / Corporate Jul 28, 2020

Astra to pay Daiichi up to $6 billion for new cancer drug

AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.

The supply chain to save the world is unprepared for a vaccine

World / Science & Health Jul 26, 2020

The supply chain to save the world is unprepared for a vaccine

by Brendan Murray and Riley Griffin

The industries that shepherd goods around the world on ships, planes and trucks acknowledge they aren’t ready to handle the epic challenges of shipping an eventual COVID-19 vaccine from drugmakers to billions of people. Already stretched thin by the pandemic, freight companies face problems ranging ...

Britain's response to COVID-19 has been world class

Commentary / World Jul 26, 2020

Britain's response to COVID-19 has been world class

by Tyler Cowen

One country has done more than any other to stop the spread of the coronavirus.

« 1 … 30 31 32 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times